At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 63 enrolled
Drug / intervention
Vitamin Ddrug
Likely dose
Vitamin D 6000 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Development of Vitamin D as a Therapy for Breast Cancer - Phase 2
In Brief
A Phase 2 clinical trial evaluating Vitamin D for Breast Cancer. Completed, enrolled 63 participants across 1 site.
Detailed Summary
This study will assess whether levels of vitamin D impact the characteristics of a woman's breast cancer at diagnosis, and whether a short course of vitamin D in women with low levels of vitamin D changes the gene expression of their breast cancers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
CollaboratorsUnited States Department of Defense
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2008
First PostedApr 2008
Primary CompletionAug 2010
Study CompletionDec 2011
TodayJul 2026
First PostedApr 10, 2008
Enrollment StartApr 1, 2008
Primary CompletionAug 1, 2010
Study CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 18.2 years ago
Interventions
Vitamin Ddrug
0, 2000, 4000, and 6000 IU per day orally